A Cleveland Clinic study finds Ozempic-style GLP-1 drugs may significantly slow the spread of several obesity-related cancers ...

New study finds bariatric surgery may deliver five times greater long-term weight loss than Ozempic and other GLP-1 ...

While semaglutide has shown impressive results in aiding weight loss, many users may experience a plateau after an initial period of significant weight loss.

Samsung and Mass General are studying whether Galaxy Watch8 can support adults starting GLP-1RA therapy by tracking activity, heart rate, body composition, and muscle changes during treatment.

The number of bariatric surgeries performed annually in the U.S. has taken a sharp drop lately, new research shows, ...

Research suggests another side effect of weight loss drugs could be changing the brain - Scientists are looking to see how ...

Many of the patients who tested the drug lost about 30 percent of their body weight — a loss comparable to the result of bariatric surgery ...

New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone.

Eli Lilly this month unveiled startling new data that showed an experimental weight-loss drug caused people with obesity to shed, on average, 28 percent of their body weight - a substantial step up ...

In the Ozempic era, not all pounds lost are met with praise. New research suggests that people may face more judgment for slimming down with the help of a GLP-1 drug than if they hadn’t lost weight at ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss — when a ...

New findings to be presented at ASCO 2026 suggest GLP-1 medicines may help reduce cancer progression, although experts say ...